The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kalidindi Ravi, Vikram Chemicals Pvt Ltd, Kakatiya ....

Filed: 11 Sep 2026, 12:40 IST Exchange: BSE Category: Insider Trading — Regulation 29(2) SAST Disclosure

Disclosure of share acquisitions by Promoter Group entities Kalidindi Ravi, Vikram Chemicals Pvt Ltd, and Kakatiya Industries Pvt Ltd through open market on 08-09-2026 and 09-09-2026. - Kalidindi Ravi acquired 18,504 shares (0.04%) on 09-09-2026 - Vikram Chemicals Pvt Ltd acquired 644,541 shares (1.42%) on 08-09-2026 & 09-09-2026 - Kakatiya Industries Pvt Ltd also disclosed acquisition details - Total equity capital remains Rs.45.23 crore comprising 4.52 crore shares - Disclosures made as per SEBI SAST Regulations 2011

Source: Original filing PDF — view on exchange portal

⚡ You're reading this after the fact — subscribers got it instantly

ISA

Indian Stock Alerts BOT

🚨 NCLIND — Quarterly Results

Revenue: ₹2,35,800 Cr (+12% YoY)

PAT: ₹19,200 Cr (+17% YoY)

EBITDA margin: 16.8%

Board declared ₹10/share dividend. Jio adds 8M subs.

📎 bseindia.com/xml-data/...

🎧 Audio summary ready

✓✓ 6:47 PM

🎧

Instant audio summaries2-min AI concall recap delivered with every earnings alert

📊

20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings

🔍

Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically

⚡

Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add NCLIND to your watchlist — all of this, automated.

14-day Pro trial · No credit card · Cancel anytime

More on NCL Industries Limited

Important. The summary above is generated automatically from NCL Industries Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.